A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplasic effect of iodine in mammary cancer
- 30 June 2009
- journal article
- Published by Elsevier BV in Prostaglandins & Other Lipid Mediators
- Vol. 89 (1-2), 34-42
- https://doi.org/10.1016/j.prostaglandins.2009.04.001
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effectsEndocrine-Related Cancer, 2008
- Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell lineEndocrine-Related Cancer, 2006
- Molecular Iodine Induces Caspase-independent Apoptosis in Human Breast Carcinoma Cells Involving the Mitochondria-mediated PathwayJournal of Biological Chemistry, 2006
- Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I−) treatment: Evidence that I2 prevents cancer promotionMolecular and Cellular Endocrinology, 2005
- Influence of Iodide and Iodolactones on Thyroid ApoptosisExperimental and Clinical Endocrinology & Diabetes, 2003
- Iodide Excess Induces Apoptosis in Thyroid Cells through a p53-Independent Mechanism Involving Oxidative StressEndocrinology, 2000
- Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand AssayMolecular Endocrinology, 1997
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δProceedings of the National Academy of Sciences of the United States of America, 1997
- Suppressive effect of iodine on DMBA-induced breast tumor growth in the ratJournal of Surgical Oncology, 1996
- Studies on the goiter inhibiting action of iodolactonesEuropean Journal of Pharmacology, 1994